MYX

M PHARMA FPO [MYX]
Mayne Pharma Group Limited, a specialty pharmaceutical company, focuses on the commercialization of women's health and dermatology pharmaceuticals in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. It operates through three segments: Women's Health, Dermatology, and International. The company provides oral drug delivery systems, as well as contract development and manufacturing services to third-party customers. It also distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.
Healthcare · ASX Small Cap
$2.7700 +0.7%

Updated 23 Jul 2026 · Signals refresh every scan

Get alerts when MYX triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track MYX — Free

Active Signals

Bullish Signals

  • MACD momentum is losing steam
  • Stochastic is deep in oversold territory — bounce conditions forming
  • Drifting lower — down 5.1% over the last 5 days
  • Beating the Small Ords index — relative strength of 1.21, so it's outpacing the pack
  • Volatility is contracting — like a spring being compressed, breakouts often follow
  • Cash positive / operating cashflow positive
  • Low P/S ratio (0.6x)
  • EPS estimates revised upward (+10pts)
  • Near 52-week low (17% of range)
  • CANSLIM I: Institutional ownership (36%)
  • Sentiment is mixed — no strong consensus either way
  • This one has been in freefall — down 54% over the past year
  • The bigger volume days are the up days — volume-weighted momentum is positive (0.44%/day)
  • Beneish M-Score -2.03 (grey zone -2.22 to -1.78): possible earnings manipulation
  • RBA hiking (-3pts)

Risk Signals

  • Below the 200-day average — the long-term trend is still working against it
  • Deeply negative margins (-20%)
  • Not enough chatter to gauge sentiment — defaulting to neutral
Ask Scout AI about MYX
"What's driving MYX today?" "How does MYX compare to peers?" "Key risks for MYX?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Mayne Pharma appoints new Chief Financial Officer
NONE Notification regarding unquoted securities - MYX
NONE Notification regarding unquoted securities - MYX

Recent ASX Announcements

2026-07-16 Mayne Pharma appoints new Chief Financial Officer
2026-07-06 Notification regarding unquoted securities - MYX
2026-07-06 Notification regarding unquoted securities - MYX
2026-07-06 Notification regarding unquoted securities - MYX
2026-07-06 Notification regarding unquoted securities - MYX

Key Metrics

$225.9M
Market Cap
212K
Avg Volume
0.7x
Vol Ratio
$2.04 — $6.50
52-Week Range
2.4%
Short Interest
N/A
Cash Runway
-20.6%
ROE
-20.4%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 80%
LLeader vs LaggardlaggardRS: -2
IInstitutional SponsorshippassInst: 36%
MMarket DirectionneutralNeutral

Sector: Healthcare

102 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
PIQ +23.3%SLD -18.1%ADR -17.9%IDT -17.1%VBS -14.3%
Compare:MYX vs PIQMYX vs SLDMYX vs ADR
Scout Pro — Deeper Analysis for MYX
Try Pro free for 30 days
Share this analysis

Track MYX and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required